SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-028325
Filing Date
2023-10-17
Accepted
2023-10-17 09:00:10
Documents
17
Period of Report
2023-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20231016_8k.htm   iXBRL 8-K 27453
2 EXHIBIT 99.1 ex_581636.htm EX-99.1 27073
7 investor_relationslogo.jpg GRAPHIC 6266
8 mbrx20231016_8kimg001.jpg GRAPHIC 3331
9 virtual_investorlogo.jpg GRAPHIC 9332
  Complete submission text file 0001437749-23-028325.txt   223094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231017.xsd EX-101.SCH 3411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231017_def.xml EX-101.DEF 11426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231017_lab.xml EX-101.LAB 15312
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231017_pre.xml EX-101.PRE 11586
11 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20231016_8k_htm.xml XML 2560
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 231328564
SIC: 2834 Pharmaceutical Preparations